The University of Michigan Health System announced yesterday that it has begun offering a new urine test that could help detect prostate cancer and save a man from an unnecessary prostate biopsy. More than 1 million men will have a prostate biopsy this year, but only about one-fifth of those biopsies will result in a cancer diagnosis.The new early detection test for prostate cancer, available through MLabs, is called Mi-Prostate Score.
The test is based on a discovery from the lab of Dr. Arul Chinnaiyan of a gene fusion (TMPRSS2:ERG) that is involved in half of prostate cancer. By looking for the gene fusion along with PSA and other urinary marker for prostate cancer, the Mi-Prostate Score improves on the accuracy of traditional PSA testing alone. The new test can help determine the likelihood of cancer and can help identify aggressive prostate cancer that may need treatment.
The test is available for U-M urology patients. for non U-M patients that wish to have this test, their doctor can send a request to the University of Michigan’s MLabs. For further information call MLabs at 800-862-7284.
Learn more about prostate cancer
Prostate Cancer Diagnosis and Treatment at the U-M Comprehensive Cancer Center
Prostate Cancer Screening and Detection at the U-M Comprehensive Cancer Center
Prostate Cancer Screening (PDQ®) from the National Cancer Institute
The University of Michigan Comprehensive Cancer Center’s 1,000 doctors, nurses, care givers and researchers are united by one thought: to deliver the highest quality, compassionate care while working to conquer cancer through innovation and collaboration. The center is among the top-ranked national cancer programs, and #1 in Michigan for cancer patient care. Seventeen multidisciplinary clinics offer one-stop access to teams of specialists for personalized treatment plans, part of the ideal patient care experience. Patients also benefit through access to promising new cancer therapies.
Since 1920, The Department of Urology has been providing care for common and complex urologic conditions. We believe in relieving urologic disease and disability through compassionate and expert care. This is accomplished by integrating the latest in treatment techniques and options with a patient centered care model.